EFS of Bioabsorbable Implant for NSD
Completed · Not applicable · NCT05967169
Conditions: Nasal Septal Deviation
At a glance
- Research payments reported, 2025
- $163,582
- U.S. investigators named
- 3
- Sites paid
- 3
- Planned or actual enrollment
- 21
About the trial
- Sponsor
- Spirair, Inc
- Tested
- Nasal Septal Strap implantation (device)
- Dates
- Started 2022-05-25; completion 2026-03-23
- Results posted
- Not yet
Early feasibility study of bioabsorbable implant and delivery device for correction of septal deviation
From ClinicalTrials.gov, last updated 2026-04-30. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Spirair, Inc. reported $163,582 in research payments for this study in 2025 (7 payments).
Products named: Septalign
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Steven E. Davis, M.D. ENT (Otolaryngology) · Torrance, CA
- Thomas S. Higgins JR., MD ENT (Otolaryngology) · Louisville, KY
- David M. Yen, M.D. Specialist · Bethlehem, PA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Kentuckiana Ear, Nose & Throat, Psc $135,336
- Breathe Clear Institute $24,973
- Specialty Physicians Associates $3,273
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.